
ERS Genomics and KU Leuven Sign CRISPR/Cas9 License Agreement to Expand
Agreement gives KU Leuven's Leuven Viral Vector Core access to foundational CRISPR/Cas9 intellectual property, supporting genome editing services for academic and industry researchers worldwideDUBLIN, and LEUVEN, Belgium…
Read report ↗









